According to the latest report by IMARC Group, titled “GCC In-vitro Diagnostic Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the in-vitro diagnostic devices market in GCC reached US$ 969 Million in 2019. In-vitro diagnostic (IVD) devices refer to medical instruments that are used to perform tests using biological samples, such as blood, urine or tissue, taken from the human body. They are available in a wide variety, ranging from simple tests to sophisticated DNA analyzers, including calibrators, kits, software, reagents, control materials and other related instruments. IVD devices play a vital role in the GCC healthcare industry as they are crucial in the diagnosis of various medical conditions and infections, and monitoring drug therapies
Request Free Sample Report: https://www.imarcgroup.com/gcc-in-vitro-diagnostic-devices-market/requestsample
The growing spread of the coronavirus disease (COVID-19) in the GCC countries has significantly boosted the market growth, as the World Health Organization (WHO) has listed two IVD tests for emergency use during the pandemic. These tests include the cobas SARS-CoV-2 Qualitative assay and Real-Time PCR Coronavirus (COVID-19). Additionally, the rising incidences of chronic diseases and the growing geriatric population are further driving the demand for IVD devices. As per the WHO, about 60% of deaths in the GCC countries are caused due to non-communicable diseases, such as diabetes, cancer and cardiovascular dysfunction. This has compelled governments of GCC countries to take initiatives to improve the healthcare services in the region. Some of these initiatives are aimed at investing in improved IVD devices, which are more accurate and efficient in executing diagnostic tests. This, along with the expanding insurance coverage under national health insurance programs, such as the Mandatory Health Insurance (MHI) schemes, to provide better and easy access to diagnostic devices, are boosting the sales of IVD devices across the region. Owing to these factors, the market value is projected to reach US$ 1,351 Million by 2025, expanding at a CAGR of 5.6% during 2020-2025.
Market Breakup by Type:
- Hospital-Based Centers
- Diagnostics Chains
- Standalone Centers
- Patient Self-Testing
- Academic Institutes
Amongst these, in-vitro diagnostic devices are majorly used in hospital-based centers.
Market Breakup by Application:
- Infectious Diseases
- Blood Test
- Autoimmune Diseases
Market Region Summary:
Region-wise, Saudi Arabia exhibits a clear dominance in the market. Other major regions include the United Arab Emirates, Kuwait, Qatar, Oman and Bahrain. The competitive landscape of the market has been examined in the report with the detailed profiles of the key players operating in the industry.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/gcc-in-vitro-diagnostic-devices-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want to need latest primary and secondary data (2020-2025) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800